Voltar
Revisão
BIBTEX RIS

The myelodysplastic syndromes

2008; Wiley; Volume: 6; Issue: 2 Linguagem: Inglês

10.1111/j.1365-2257.1984.tb00532.x

ISSN

1365-2257

Autores

D. A. G. Galton,

Tópico(s)

Acute Lymphoblastic Leukemia research

Resumo

Clinical & Laboratory HaematologyVolume 6, Issue 2 p. 99-112 Free Access The myelodysplastic syndromes D.A.G. GALTON MA, MD, FRCP, Corresponding Author D.A.G. GALTON MA, MD, FRCP Medical Research Council Leukaemia Unit, Royal Postgraduate Medical School, LondonProf. D. A. G. Galton, MRC Leukaemia Unit, Royal Postgraduate Medical School, DuCane Road, London W12 OHS.Search for more papers by this author D.A.G. GALTON MA, MD, FRCP, Corresponding Author D.A.G. GALTON MA, MD, FRCP Medical Research Council Leukaemia Unit, Royal Postgraduate Medical School, LondonProf. D. A. G. Galton, MRC Leukaemia Unit, Royal Postgraduate Medical School, DuCane Road, London W12 OHS.Search for more papers by this author First published: June 1984 https://doi.org/10.1111/j.1365-2257.1984.tb00532.xCitations: 35AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References BACCARANI M & TURA S (1979) Differentiation of myeloid leukaemic cells: new possibilities for therapy. Br. J. Haematol 42, 485– 487. BACCARANI M, ZACCARIA A, BANDINI G, CAVAZZINI G, FANIN R & TURA S (1983) Low-dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia. Leuk. Res. 7, 539– 545. BALDINI M, FUDENBERG H. H, FUKUTAKE K & DAMESHEK W (1959) The anemia of the Di Guglielmo syndrome. Blood 14, 334. BENNETT J. M, CATOVSKY D, DANIEL M.-T., FLANDRIN G, GALTON D. A. G, GRALNICK H. R & SULTAN C (1976) Proposals for the classification of the acute leukaemias. Br. J. Haematol. 33, 451– 458. BENNETT J. M, CATOVSKY D, DANIEL, M.-T. FLANDRIN, G, GALTON, D. A. G, GRALNICK H. R & SULTAN C (1982). Proposals for the classification of the myelodysplastic syndromes. Br. J, Haematol. 51, 189– 199. BERK P. D & WASSERMAN L. R (1981) Acute leukemia in polycythemia vera. N. Engl. J. Med. 305, 342– 343. BERNARD J, IZRAEL V & JACQUILLAT C (1975) Les leucémies oligoblastiques. Nouv. Presse Med. 4, 943. BJÖRKMAN S. E. (1956) Chronic refractory anaemia with sideroblastic bone marrow. A study of four cases. Blood 11, 250– 259. BLOCK M, JACOBSON L. O & BETHARD W. F (1953) Preleukemic acute human leukemia. J. Am. Med. Assoc. 152, 1018– 1029. BOMFORD R. R & RHOADS C. P (1941) Refractory anaemia. I. Clinical and pathological aspects. Q. J. Med. 10, 175. BOOGAERTS M. A, NELISSEN V, ROELANT C & GOOSSENS W (1983) Blood neutrophil function in primary myelodysplastic syndromes. Br. J. Haematol. 55, 217– 227. BUCKMAN R, CUZICK J & GALTON D. A. G (1982) Long-term survival in myelomatosis. A report to the MRC Working Party on Leukaemia in Adults. Br. J. Haematol. 52, 589– 599. CASTAIGNE S, DANIEL M.-T., TILLY H, HERAIT P & DEGOS L (1983) Does treatment with ARA-C in low dosage cause differentiation of leukemic cells Blood 62, 85– 86. COLTMAN C. A. (1982) Treatment related leukemia. In Cancer Treatment and Research Vol. 5. Adult Leukemias I, ed. C. D. Bloomfield pp. 61– 108. Martinus Nijhoff, London . DACIE J. V, SMITH M. D, WHITE J. C & MOLLIN D. L (1959) Refractory normblastic anaemia: a clinical and haematological study of seven cases. Br. J. Haematol. 5, 56– 82. DAMESHEK W & BALDINI M (1958) The Di Guglielmo Syndrome. Blood 13, 192– 194. DAMESHEK W & GUNZ F. W (1958) Leukemia, p. 16. Grune & Stratton, New York . DESFORGES J. F. (1983) Cytarabine: low-dose, high-dose, no dose N. Engl. J. Med. 309, 1637– 1638. DOHY H, GENOT J. Y, IMBERT M, RICARD, D 'AGAY, M. F. & SULTAN C (1980) Myelodysplasia and leukaemia related to chemotherapy and/or radiotherapy a haematological study of 13 cases. Values of macrocytosis as an early sign of bone marrow injury, Clin. lab. Haemat. 2, 111– 119. DREYFUS B, ROCHANT H, SALMON C, BOIVIN P, SULTAN C, MANNONI P, GALAND C & CARTRON J. P (1968) Anémíes réfractaires, états préleucémiques et anomalies enzymatiques multiples. Comptes Rend. Acad. Sci. (Paris) Serie D 266, 1627– 1630. DREYFUS B, ROCHANT H & SULTAN C (1969) Anémies réfractaires: enzymopathies acquises des cellules souches hématopoiétiques. Nouv. Rev. Fr. Hematol. 9, 65– 86. DREYFUS, B., SULTAN C, ROCHANT H, SALMON C, MANNONI P, CASTRON J. P, BIOVIN P & GALAND C (1969) Anomalies of blood group antigens and erythrocyte enzymes in two types of chronic refractory anaemia. Br. J. Haematol. 16, 303– 312. DREYFUS B, ROCHANT H, SULTAN C, CLAUVEL J. P, YVART J & CHESNEAU A. M (1970) Les anémies réfractaires avec excés de myéloblastes dans la moelle. Étude de 11 observations. Nouv. Presse Med. 78, 359– 364. DREYFUS B. (1976) Preleukemic states. I. Definition and classification. II. Refractory anemia with excess of myeloblasts in the bone marrow (smoldering acute leukemia). Blood Cells 2, 33– 35. FOUCAR K, MCKENNA R. W, BLOOMFIELD C. D, BOWERS T. K & BRUNNING R. D (1979) Therapy-related leukemia. A panmyelosis. Cancer 43, 1285– 1296. HEILMEYER L, KEIDERLING W, BILGER R & BERNAUER H (1958) Über chronischc refraktäre Anäemien mil sideroblastichen Knochenmark (Anaemia refractoria sideroblastica). Folia Haemal. (Frankfurt) NF 2, 49– 60. HERZIG R. H, WOLFF S. N, LAZARUS H. M, PHILLIPS G. L, KARANES C & HERZIG G. P (1983) High-dose cytosine arabinoside therapy for refractory leukemia. Blood 62, 361– 369. HOUSSET M, DANIEL M.-T. & DEGOS L (1982) Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells Br. J. Haematol. 51, 125– 129. JOSEPH A. S, CINKOTAL K. I, HUNT L & GEARY C. G (1982) Natural history of smouldering leukaemia. Br. J. Cancer 46, 160– 166. JUNEJA S. K, IMBERT M, JOUAULT H, SCOAZEC J.-Y., SIGAUX F & SULTAN C (1983) Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases. J. din. Pathol. 36, 1129– 1135. KYLE R. A, PIERRE R. V & BAYRD E. D (1970) Multiple myeloma and acute myelomonocytic leukemia. N. Engl. J. Med. 283, 1121– 1125. LINMAN J. W & SAARNI M. I (1974) The pre-leukemic syndrome. Semin. Hematol. 11, 93. LINMAN J. W & BAGBY G. C (1976) The preleukemic syndrome: clinical and laboratory features, natural course and management. Blood Cells 2, 11– 31. MACGIBBON B & MOLLIN D. L (1965) Sideroblastic anaemia in man: observations on seventy cases. Br. J. Haematol. 11, 59– 69. MEYES D, KATZ D & RAMOT B (1976) Preleukcmia and leukemia in polycythemia vcra. Blood 47, 237– 241. MOLONEY W. C & ROSRNTHAL D. S (1981) Treatment of early acute nonlymphatic leukemia with low dose cytosine arabinoside. Hämatol. Bluttrans. 26, 59– 62. MUFTI G. J, OSCIER D. G, HAMBLIN T. J & BELL A. J (1983) Low doses of cytarabine in the treatment of myelodysplastic syndrome' and acute myeloid leukemia. N. Engl. J. Med. 309, 1653– 1654. MURRAY C, COOPER B & KITCHENS L. W (1983) Remission of acute myelogenous leukemia in elderly patients with prior refractory dysmyelopoietic anemia. Cancer 52, 967– 970. NAJEAN Y & PECKING A (1977) Refractory anaemia with excess of myeloblasts in the bone marrow: a clinical trial of androgens in 90 patients. Br. J. Haematol. 37, 25– 33. NIELSEN B, THIEDE T & CARLSSON M (1983) Myelodysplastic syndrome in polycythaemia vera. Br. J. Haematol. 55, 193– 194. NOWELL P. C. (1965) Prognostic value of marrow chromosome studies in human ‘preleukaemia. Arch. Pathol. 80, 205. NOWELL P. C. (1971) Marrow chromosome studies in ‘preleukemia': further correlation with clinical course. Cancer 28, 513. NOWELL P. C & FINAN J (1978) Chromosome studies in preleukemic states. Cancer 42, 2254– 2261. PEDERSEN-BJERGAARD J & LARSEN S. O (1982) Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. N. Engl. J. Med. 307, 965– 971. PIERRE R. V. (1975) Cytogenetic studies in preleukemia: studies before and after transition to acute leukemia in 17 subjects. Blood Cells 1, 163– 170. RHEINGOLD J. J, KAUFMAN R, ADELSON E & LEAR A (1963) Smoldering acute leukemia. N. Engl. J. Med. 268, 812– 815. RHOADS C. P & BARKER W. H (1938) Refractory anemia: analysis of 100 cases. J. Am. Med. Assoc. 110, 794. SAARNI M. I & LINMAN J. W (1973) Preleukemia: the hematologic syndrome preceding acute leukemia. Am. J. Med. 55, 38– 48. SACHS L. (1978) The differentiation of myeloid leukaemia cells: new possibilities for therapy. Br. J. Haematol. 40, 509– 517. SCOTT C. S, CAHILL A, BYNOE A. G, AINLEY M. J, HOUGH D & ROBERTS B. E (1983) Esterase cytochemistry in primary myelodysplastic syndromes and megaloblastic anaemias: demonstration of abnormal staining patterns associated with dysmyelopoiesis. Br. J. Haematol. 55, 411– 418. SECOND INTERNATIONAL WORKSHOP ON CHROMOSOMES IN LEUKEMIA (1980) Chromosomes in preleukemia. Canc. Genet. Cytogenet. 2, 108– 113. SEIGNEURIN D & AUDHUY B (1982) Significance of agranular myeloblasts in refractory anaemia with excess of myeloblasts in the bone marrow. Br. J. Haematol. 52, 164– 165. SEIGNEURIN D. (1983) Refractory anaemia with excess of blasts in transformation: is a new category necessary Br. J. Haematol. 55, 196. SOKAL G, MICHAUX J. L, VAN DEN BERGHE H, CORDIER A, RODHAIN J, FERRANT A, MORIAN M, DE BRUYERE M & SONNET J (1975) A new hematological syndrome with a distinct karyotype: the 5q-chromosome. Blood 46, 519. SCOTT H, FOX W, GIRLING D. J, STEPHENS R. J & GALTON D. A. G (1977) Acute leukaemia after busulphan. Br. Med. J. ii, 1513. SULTAN, C. SIGAUX, F, IMBERT, M & REYES F (1981) Acute myelodysplasia with myelofibrosis: a report of eight cases. Br. J. Haemal. 49, 11– 16. TINEGATE H, GAUNT L & HAMILTON P. J (1983) The 5q-syndrome: an under-diagnosed form of macrocytic anaemia. Br. J. Haematol. 54, 103– 110. TODD W. M & PIERRE R. V (1983) Preleukemia: a long term prospective study of 326 patients. Blood 62, (Suppl. 1) 184a. VALLESPI M. T, TORRABADELL M, IRRIGUIBLE D, JAEN A, ACEBEDO G, PUJOL A & TRIGINER J (1983) Myelodysplastic syndromes: a study of 101 cases according to the FAB classification. Proceedings of the 7th Meeting of the European and African Division of the Int. Soc. Hemat. Barcelona , p. 277. VAN DEN BERGHE H, CASSIMAN J, DAVID G, FRYNS J.-P., MICHAUX J & SOKAL G (1974) Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature 251, 437– 438. VARELA B. L, CHUANG C & BENNETT J. M (1982) Clinical significance of the new proposals for the classification of the myelodysplastic syndromes. Blood 60, (Suppl. 1) 140a. WEISDORF D. J, OKEN M. M, JOHNSON G. J & RYDELL R. E (1983) Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia. Br. J. Haematol. 55, 691– 700. WILKINSON J. F & ISRAELS M. C. G (1935) Achrestic anaemia. Br. med. J. I, 139. WISCM J. S, GRIFFIN J. D & KUFE D. W (1983) Response of preleukemic syndromes to continuous infusion of low-dose cytarabine. N. Engl. J. Med. 309, 1599– 1602. WOODRUFF R. K, BUNCE I. H, JOHNSON S, PAXTON A. M & MALPAS J. J (1981) Use of the FAB criteria for the diagnosis of acute erythroleukaemia (AEL). Aust. NZ J. Med. 11, 1– 7. Citing Literature Volume6, Issue2June 1984Pages 99-112 ReferencesRelatedInformation

Referência(s)